%0 Journal Article
%T Is three always greater than two?—azacitidine, venetoclax, and gilteritinib triple therapy in newly diagnosed and relapsed/refractory FLT3-mutant acute myeloid leukemia
%A Jones, Matthew F.
%A Smith, Catherine C.
%J AME Clinical Trials Review
%D 2024
%B 2024
%9 
%! Is three always greater than two?—azacitidine, venetoclax, and gilteritinib triple therapy in newly diagnosed and relapsed/refractory FLT3-mutant acute myeloid leukemia
%K 
%X 
%U https://actr.amegroups.org/article/view/9960
%V 2
%P 
%@ 3005-6152